APLAR recommendations on the practice of telemedicine in rheumatology.

Select Content Type
Clinical Guidelines
Authored By
Ahmed S, Grainger R, Santosa A, Adnan A, Alnaqbi KA, Chen YH, Kavadichanda C, Kaw NSK, Kelly A, Khan SEA, Masri B, Nakarmi S, Parlindungan F, Rahman N, So H, Soroush MG, Thilakarathne AS, Traboco L
Authored On
Interests
Rheumatology
Speciality
Rheumatology
Book Detail
volume
25
ISSN
1756-185X
Publication Date
Actions
Download in App
Event Data
{"article_title":"APLAR recommendations on the practice of telemedicine in rheumatology.","author":"Ahmed S, Grainger R, Santosa A, Adnan A, Alnaqbi KA, Chen YH, Kavadichanda C, Kaw NSK, Kelly A, Khan SEA, Masri B, Nakarmi S, Parlindungan F, Rahman N, So H, Soroush MG, Thilakarathne AS, Traboco L","journal_title":"International journal of rheumatic diseases","issn":"1756-185X","isbn":"","publication_date":"2022-03-01","volume":"25","issue":"3","first_page":"247","page_count":"","accession_number":"35043576","doi":"","publisher":"Wiley on behalf of the Asia Pacific League of Associations for Rheumatology","doctype":"Journal Article","subjects":"Asia; COVID-19; Rheumatology standards; Telemedicine standards; Asia; Consensus; Humans; SARS-CoV-2","interest_area":["Rheumatology"],"abstract":"Introduction: The COVID-19 pandemic led to rapid and widespread adoption of telemedicine in rheumatology care. The Asia Pacific League of Associations for Rheumatology (APLAR) working group was tasked with developing evidence-based recommendations for rheumatology practice to guide maintenance of the highest possible standards of clinical care and to enable broad patient reach. Materials and Methods: A systematic review of English-language articles related to telehealth in rheumatology was conducted on MEDLINE\/PubMed, Web Of Science and Scopus. The strength of the evidence was graded using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach as well as the Oxford Levels of Evidence. The recommendations were developed using a modified Delphi technique to establish consensus. Results: Three overarching principles and 13 recommendations were developed based on identified literature and consensus agreement. The overarching principles address telemedicine frameworks, decision-making, and modality. Recommendations 1-4 address patient suitability, triage, and when telemedicine should be offered to patients. Recommendations 5-10 cover the procedure, including the means, data safety, fail-safe mechanisms, and treat-to-target approach. Recommendations 11-13 focus on training and education related to telerheumatology. Conclusion: These recommendations provide guidance for the approach and use of telemedicine in rheumatology care to guide highest possible standards of clinical care and to enable equitable patient reach. However, since evidence in telemedicine care in rheumatology is limited and emerging, most recommendations will need further consideration when more data are available. \u00a9 2022 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=35043576","isPdfLink":true,"isSAML":false,"an":"35043576","number_other":"","type_pub":"","issn_electronic":"1756-185X","languages":"English","language":"eng","date_entry":"","date_update":"","titleSource":"International journal of rheumatic diseases [Int J Rheum Dis] 2022 Mar; Vol. 25 (3), pp. 247-258. Date of Electronic Publication: 2022 Jan 19.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2022-03-01","description":"Introduction: The COVID-19 pandemic led to rapid and widespread adoption of telemedicine in rheumatology care. The Asia Pacific League of Associations for Rheumatology (APLAR) working group was tasked with developing evidence-based recommendations for rheumatology practice to guide maintenance of the highest possible standards of clinical care and to enable broad patient reach.<br \/>Materials and Methods: A systematic review of English-language articles related to telehealth in rheumatology was conducted on MEDLINE\/PubMed, Web Of Science and Scopus. The strength of the evidence was graded using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach as well as the Oxford Levels of Evidence. The recommendations were developed using a modified Delphi technique to establish consensus.<br \/>Results: Three overarching principles and 13 recommendations were developed based on identified literature and consensus agreement. The overarching principles address telemedicine frameworks, decision-making, and modality. Recommendations 1-4 address patient suitability, triage, and when telemedicine should be offered to patients. Recommendations 5-10 cover the procedure, including the means, data safety, fail-safe mechanisms, and treat-to-target approach. Recommendations 11-13 focus on training and education related to telerheumatology.<br \/>Conclusion: These recommendations provide guidance for the approach and use of telemedicine in rheumatology care to guide highest possible standards of clinical care and to enable equitable patient reach. However, since evidence in telemedicine care in rheumatology is limited and emerging, most recommendations will need further consideration when more data are available.<br \/> (© 2022 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.)","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=35043576&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Ahmed S, Grainger R, Santosa A, Adnan A, Alnaqbi KA, Chen YH, Kavadichanda C, Kaw NSK, Kelly A, Khan SEA, Masri B, Nakarmi S, Parlindungan F, Rahman N, So H, Soroush MG, Thilakarathne AS, Traboco L","header":{"DbId":"mdl","DbLabel":"MEDLINE Ultimate","An":"35043576","RelevancyScore":"915","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"914.601135253906"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=mdl&AN=35043576&authtype=shib&custid=ns346513&group=main&profile=eds","physicalDescription":{"Pagination":{"StartPage":"247"}},"additionalInfo":{"Authored_By":"Ahmed S, Grainger R, Santosa A, Adnan A, Alnaqbi KA, Chen YH, Kavadichanda C, Kaw NSK, Kelly A, Khan SEA, Masri B, Nakarmi S, Parlindungan F, Rahman N, So H, Soroush MG, Thilakarathne AS, Traboco L","Journal_Info":"Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1756-185X (Electronic) Linking ISSN: 17561841 NLM ISO Abbreviation: Int J Rheum Dis Subsets: MEDLINE","Publication_Type":"Journal Article; Practice Guideline","Published_Date":"2022-03-01","Source":"International journal of rheumatic diseases [Int J Rheum Dis] 2022 Mar; Vol. 25 (3), pp. 247-258. Date of Electronic Publication: 2022 Jan 19.","Languages":"English","Electronic_ISSN":"1756-185X","MeSH_Terms":"COVID-19*, Rheumatology\/*standards , Telemedicine\/*standards, Asia ; Consensus ; Humans ; SARS-CoV-2","Subjects":"Asia, Consensus, Humans, SARS-CoV-2, COVID-19, Rheumatology standards, Telemedicine standards","Title_Abbreviations":"International journal of rheumatic diseases","Volume":"25"}}
ISSN
1756-185X
IS_Ebsco
true
Additional Info
["Ahmed S, Grainger R, Santosa A, Adnan A, Alnaqbi KA, Chen YH, Kavadichanda C, Kaw NSK, Kelly A, Khan SEA, Masri B, Nakarmi S, Parlindungan F, Rahman N, So H, Soroush MG, Thilakarathne AS, Traboco L","Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1756-185X (Electronic) Linking ISSN: 17561841 NLM ISO Abbreviation: Int J Rheum Dis Subsets: MEDLINE","Journal Article; Practice Guideline","2022-03-01","International journal of rheumatic diseases [Int J Rheum Dis] 2022 Mar; Vol. 25 (3), pp. 247-258. Date of Electronic Publication: 2022 Jan 19.","English","1756-185X","COVID-19*, Rheumatology\/*standards , Telemedicine\/*standards, Asia ; Consensus ; Humans ; SARS-CoV-2","Asia, Consensus, Humans, SARS-CoV-2, COVID-19, Rheumatology standards, Telemedicine standards","International journal of rheumatic diseases","25"]
Description

Introduction: The COVID-19 pandemic led to rapid and widespread adoption of telemedicine in rheumatology care. The Asia Pacific League of Associations for Rheumatology (APLAR) working group was tasked with developing evidence-based recommendations for rheumatology practice to guide maintenance of the highest possible standards of clinical care and to enable broad patient reach.<br />Materials and Methods: A systematic review of English-language articles related to telehealth in rheumatology was conducted on MEDLINE/PubMed, Web Of Science and Scopus. The strength of the evidence was graded using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach as well as the Oxford Levels of Evidence. The recommendations were developed using a modified Delphi technique to establish consensus.<br />Results: Three overarching principles and 13 recommendations were developed based on identified literature and consensus agreement. The overarching principles address telemedicine frameworks, decision-making, and modality. Recommendations 1-4 address patient suitability, triage, and when telemedicine should be offered to patients. Recommendations 5-10 cover the procedure, including the means, data safety, fail-safe mechanisms, and treat-to-target approach. Recommendations 11-13 focus on training and education related to telerheumatology.<br />Conclusion: These recommendations provide guidance for the approach and use of telemedicine in rheumatology care to guide highest possible standards of clinical care and to enable equitable patient reach. However, since evidence in telemedicine care in rheumatology is limited and emerging, most recommendations will need further consideration when more data are available.<br /> (© 2022 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.)

Published Date